Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, 59 Daesagwan-ro, Yongsan-gu, Seoul, 04401, Republic of Korea.
Elim Thyroid Clinic, Seoul, Korea.
BMC Nephrol. 2023 Mar 22;24(1):64. doi: 10.1186/s12882-023-03111-7.
Chronic kidney disease (CKD) has a significant impact on global health. Studies have shown that subclinical thyroid dysfunction may be related to CKD, but the association between subclinical thyroid dysfunction and CKD in the general population is unclear. We aimed to evaluate the risk of CKD according to thyroid function status in a large cohort.
We analyzed data from a nationwide, population-based, cross-sectional survey (KNHANES VI). A total of 3,257 participants aged ≥ 19 years who underwent thyroid and kidney function assessments were included in this study. CKD was defined as an estimated glomerular filtration rate < 60 mL/min/1.73 m and/or urine albumin-creatinine ratio ≥ 30 mg/g. The risk of CKD according to thyroid function status was assessed using logistic regression, adjusted for potential confounders.
Overall, 6.7% of the participants had CKD. There were no significant differences in thyroid-stimulating hormone and free thyroxine levels between the groups with and without CKD. The proportion of participants with CKD was significantly different among the thyroid function status groups (p = 0.012) and tended to increase significantly in the following order: subclinical hyperthyroidism (1.5%), euthyroidism (6.6%), and subclinical hypothyroidism (12.6%) (p for trend < 0.001). Subclinical hypothyroidism was a significant risk factor for CKD, even after adjusting for sex, age, household income, education, smoking, alcohol consumption, walking activity, abdominal obesity, hypertension, low high-density lipoprotein cholesterol, elevated triglycerides, hyperglycemia, free thyroxine, and thyroid-peroxidase anibody (odds ratio 2.161, 95% confidence interval 1.032-4.527, p = 0.041).
Subclinical hypothyroidism is an independent predictor of CKD in the general population.
慢性肾脏病(CKD)对全球健康有重大影响。研究表明,亚临床甲状腺功能障碍可能与 CKD 有关,但普通人群中亚临床甲状腺功能障碍与 CKD 之间的关系尚不清楚。我们旨在通过对大型队列的甲状腺功能状态评估,评估 CKD 的风险。
我们分析了全国性、基于人群的横断面调查(KNHANES VI)的数据。共纳入 3257 名年龄≥19 岁并接受甲状腺和肾功能评估的参与者。CKD 定义为估算肾小球滤过率<60 mL/min/1.73 m2和/或尿白蛋白/肌酐比值≥30 mg/g。使用逻辑回归评估甲状腺功能状态与 CKD 风险的关系,并调整潜在混杂因素。
总体而言,6.7%的参与者患有 CKD。CKD 组和非 CKD 组的促甲状腺激素和游离甲状腺素水平无显著差异。甲状腺功能状态组之间的 CKD 发生率存在显著差异(p=0.012),且呈递增趋势:亚临床甲状腺功能亢进(1.5%)、甲状腺功能正常(6.6%)和亚临床甲状腺功能减退(12.6%)(趋势 p<0.001)。亚临床甲状腺功能减退是 CKD 的一个显著危险因素,即使在校正性别、年龄、家庭收入、教育程度、吸烟、饮酒、步行活动、腹型肥胖、高血压、低高密度脂蛋白胆固醇、甘油三酯升高、高血糖、游离甲状腺素和甲状腺过氧化物酶抗体后(比值比 2.161,95%置信区间 1.032-4.527,p=0.041)。
亚临床甲状腺功能减退是普通人群 CKD 的独立预测因子。